A59Delivery risk: AmberGate: pending
Controls on what feeds amplify
Proposed new action A59; sourced research home and appraisal design; scope and funding remain provisional.
Provisional single-reviewer assessment; not an approved business case.
- Who and where
- Population not yet defined. Jurisdiction: not defined.
- Result so far
- Range if completed: 14.0–20.0 out of 30 (equal weights; not yet assessed: expected incremental benefit (Bn), incremental affordability (Co))
- Funded now (baseline)
- Funded baseline not yet stated
- The change assessed (marginal)
- Marginal change not yet defined
- Domain home: Media
- In the national plan: Kept outside the national lists
What the evidence supports—and the next decision
Feed exposure and harm are not interchangeable measures. The net effect of a particular amplification control remains design-dependent.
AI-assisted analytical follow-up · 8 October 2026. Proposed appraisal design; the attributed scores below are unchanged. No funding or delivery agreement is implied.
- Define the change
- Specify one recommender-system change and eligible content, with independent access to an auditable test and comparison condition.
- Test whether it works
- Exposure to the defined harm, user wellbeing and unintended suppression, with age-specific measures. Engagement is not a wellbeing outcome.
- Establish the cost
- Engineering, researcher access, audits, enforcement and appeals; separate a pilot from continuing regulation.
- Protect against harm
- Protect privacy, expression and lawful content. Publish false-positive and appeal outcomes; no broad censorship score follows from a reach statistic.
Read with the outcome evidence and sources in the full assessment. Monitoring proposals are not existing baseline measurements. A numerical benefit or cost score needs evidence for the defined increment, not just the scale of the problem.
Full assessment of Controls on what feeds amplify: ten criteria, scenarios, delivery, costs and monitoring
The ten criteria (0–3)
Each criterion is scored 0 to 3 by the reviewer. “Not yet assessed” means unknown: it is never counted as zero.
Scale and severity (Sc)2 of 3 — Serious harm to a defined group or widespread moderate harm
Reviewer’s reason: Provisional problem-importance judgement from linked site pages; not the scale of achievable benefit.
Increment beyond baseline (Ad)2 of 3 — Specific material change to existing delivery
Reviewer’s reason: Specify ranking intervention and trial agreement; independent researcher access, consent/privacy safeguards and meaningful outcomes; separate later regulation. A missing rating requires a defined marginal change.
Confidence in the proposed action (Ev)1 of 3 — Indirect, mixed, modelled or weak causal support
Reviewer’s reason: Artifact cites platform experiments but mixed attitude effects; UK wellbeing benefit and transfer are not established.
Expected incremental benefit (Bn)Not yet assessed
Reviewer’s reason: Unknown unless a reasonably defined target-population benefit can be judged; no bonus merely for spanning domains.
Residual harms (Hm)1 of 3 — Material harm/unresolved mitigation
Reviewer’s reason: Expression/privacy risks; unintended engagement and exposure effects.
Incremental affordability (Co)Not yet assessed
Reviewer’s reason: Platform engineering, independent research, auditing, enforcement and compliance; a cheap pilot is not a costed regulatory system.
Delivery capacity (Ca)2 of 3 — Stretched but plausibly obtainable
Reviewer’s reason: Specify ranking intervention and trial agreement; independent researcher access, consent/privacy safeguards and meaningful outcomes; separate later regulation.
Distribution (Fa)2 of 3 — Mixed or broadly neutral with safeguards
Reviewer’s reason: Provisional distribution judgement for the stated target; verify who pays, who gains and excluded groups.
Meaningful first outcome (Ti)2 of 3 — More than one and up to three years
Reviewer’s reason: First meaningful outcome, not announcement: Exposure, wellbeing and attitudes, alongside expression and privacy outcomes.
Readiness (Rd)2 of 3 — Named commissioning/allocation/coordination step
Reviewer’s reason: Researchers, platforms and regulators; government/Parliament for legal changes; UK mechanism and outcome study
Four weightings
Normalised as 10 × weighted sum ÷ sum of weights, on a 0–30 scale. Where a criterion is not yet assessed, the range is the lowest and highest result if it were later scored 0 or 3 — not a score, a confidence interval or a rank.
- Equal weights: Range if completed: 14.0–20.0 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
- Evidence doubled: Range if completed: 13.6–19.1 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
- Scale doubled: Range if completed: 14.5–20.0 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
- Cost ignored (the funding gate still applies): Range if completed: 15.6–18.9 out of 30. Not yet assessed: expected incremental benefit (Bn), incremental affordability (Co). Funding gate: not passed.
Funding gate: Not passed — the cost is not yet assessed or no allocation is committed for this scope. Ignoring cost in a weighting never removes the gate.
Delivery risk and gate
Delivery risk shown: AmberReview’s claim: Amber. Best the recorded evidence allows: Amber.
Review’s reason: Platform engineering, independent research, auditing, enforcement and compliance; a cheap pilot is not a costed regulatory system.
Why it is not Green yet
- Scope (population, place and increment) not verified against the delivery baseline.
- No verified owner with the powers in place.
- Delivery capacity not verified.
- Lifetime incremental costs not complete.
- No credible funding (a committed allocation for the scope).
- Safeguards not specified.
- Monitoring lacks a metric, a data source or a baseline.
Green needs verified scope, a verified owner with the powers, verified capacity, complete lifetime costs with credible funding, specified safeguards and monitoring with a metric, source and baseline. Amber means appraisal gaps remain; Red means a material delivery obstacle. Red does not mean unimportant.
Gate: Pending — appraisal incomplete (review label: “Pending: incomplete appraisal”).
Why: Scores incomplete; Funding gate not passed (cost unknown or no credible funding).
The gate is separate from national list membership: being listed does not make an option eligible, and an eligible option need not be listed.
Cost and funding
Lifetime costing: Not established. Review: “Full incremental costing not established in reviewed material”.
Still to cost: Platform engineering, independent research, auditing, enforcement and compliance; a cheap pilot is not a costed regulatory system.
Funding status: not established in review.
Owner, powers and capacity
Proposed owner: Researchers, platforms and regulators; government/Parliament for legal changes (proposed, unverified).
Powers: needs a decision or allocation. Capacity: unverified.
Powers and capacity read from the review’s Rd and Ca anchors; no proposed owner has agreed to act (the review: “Proposed owners have not agreed to act”).
- England:
- not assessed
- Scotland:
- not assessed
- Wales:
- not assessed
- Northern Ireland:
- not assessed
Not defined in the review.
Dependencies, safeguards and risks
Depends on: None recorded.
Safeguards
- independent researcher access, consent/privacy safeguards and meaningful outcomes (proposed, not yet specified)
Risks and residual harms: Expression/privacy risks; unintended engagement and exposure effects.
Monitoring and measured results
Metric: Exposure, wellbeing and attitudes, alongside expression and privacy outcomes.
Data source: Not yet named. Baseline: Not yet established.
Evidence for the outcome
Outcome: Exposure, wellbeing and attitudes, alongside expression and privacy outcomes.
Artifact cites platform experiments but mixed attitude effects; UK wellbeing benefit and transfer are not established.
SWOT points it addresses
- Reach, trust and influence are different things: Meta reaches 51% of adults with news, more than newspapers’ 44%, while only 30% of UK respondents trust most news most of the time. (Media)
- The 10 largest platforms are regulated for online safety; duties on news publisher content and content of democratic importance are not yet in force — Ofcom’s consultation on them closed on 2 October 2026 and its decisions are pending — and no UK rule covers the plurality of what feeds select. (Media)
Review record
Assessment status: Provisional single-reviewer assessment; not an approved business case.
Reviewer: Original assessment author (name not supplied). Reviewed: 6 October 2026.
Scored in the working review of 6 October 2026 on the shared ten-criterion scale (one reviewer); not independently calibrated.
First 90 days (review): Produce a signed scope and current-delivery baseline; Specify ranking intervention and trial agreement; independent researcher access, consent/privacy safeguards and meaningful outcomes; separate later regulation. Obtain incremental costs and an accountable decision before expansion.
Decision route: UK mechanism and outcome study
An editorial screening framework by one reviewer, not a formal appraisal or business case. Proposed owners have not agreed to act.